Argus Research Initiates Coverage On 10x Genomics with Buy Rating, Announces Price Target of $110
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsInitiationPrice Target
Argus Research analyst John Eade initiates coverage on 10x Genomics (NASDAQ:TXG) with a Buy rating and announces Price Target of $110.
Argus Research analyst John Eade initiates coverage on 10x Genomics (NASDAQ:TXG) with a Buy rating and announces Price Target of $110.